#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2904	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2459	346.8	0	.	n	.	0	C451T	SNP	451	451	C	916	916	T	401	T,C	269,90	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2904	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2459	346.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1649	1649	C	431	C	388	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2904	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2459	346.8	0	HET	.	.	.	C328G,A	.	328	328	C	793	793	C	387	C,G,A	266,87,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2904	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2459	346.8	0	HET	.	.	.	C1450T,A	.	1450	1450	C	1915	1915	C	450	C,T,A	294,113,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2904	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2459	346.8	0	HET	.	.	.	C207T	.	207	207	C	672	672	C	382	C,T	257,80	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4426	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4060	326.3	0	.	n	.	0	T695C	SNP	695	695	T	1300	1300	C	341	C	306	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4426	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4060	326.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2576	2576	C	384	C,T	341,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4426	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4060	326.3	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3202	3202	T	323	T,G	284,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4426	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4060	326.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2650	2650	A	386	A,G	352,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	502	folP	855	855	100.0	folP.l15.c4.ctg.1	2012	74.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1333	1335	AGC	117;118;119	A;G,T;C	98;102,1;100	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1036	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3939	78.8	1	SNP	p	S91F	1	.	.	271	273	TTC	897	899	TTC	89;90;91	T;T;C	79;79;81	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1036	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3939	78.8	1	SNP	p	D95G	1	.	.	283	285	GGC	909	911	GGC	94;94;94	G;G;C	82;85;82	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1036	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3939	78.8	1	SNP	p	G95N	0	.	.	283	285	GGC	909	911	GGC	94;94;94	G;G;C	82;85;82	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	400	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1863	64.1	1	SNP	p	G45D	0	.	.	133	135	GGC	678	680	GGC	110;110;110	G;G;C	102;96;98	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	282	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	1608	52.4	0	.	n	.	0	A197.	DEL	197	197	A	900	900	A	104	A	97	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1058	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3413	92.6	1	SNP	p	D86N	0	.	.	256	258	GAC	871	873	GAC	119;119;119	G;A;C	111;108;106	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1058	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3413	92.6	1	SNP	p	S87R	1	.	.	259	261	CGT	874	876	CGT	119;119;118	C;G;T	113;111;109	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1058	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3413	92.6	1	SNP	p	R87W	0	.	.	259	261	CGT	874	876	CGT	119;119;118	C;G;T	113;111;109	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1058	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3413	92.6	1	SNP	p	R87I	0	.	.	259	261	CGT	874	876	CGT	119;119;118	C;G;T	113;111;109	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1058	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3413	92.6	1	SNP	p	S88P	0	.	.	262	264	TCC	877	879	TCC	117;118;117	T;C;C	107;110;111	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	752	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3171	71.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1826	1828	GGC	79;79;78	G;G;C	70;69;69	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	782	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2745	85.0	1	SNP	p	A311V	0	.	.	931	933	GCC	1398	1400	GCC	108;108;109	G;C;C,A	97;96;95,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	782	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2745	85.0	1	SNP	p	I312M	1	.	.	934	936	ATG	1401	1403	ATG	109;109;109	A;T;G,C	99;97;96,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	782	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2745	85.0	1	SNP	p	V316T	1	.	.	946	948	ACC	1413	1415	ACC	114;115;114	A,G;C,T;C,G	98,1;99,1;97,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	782	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2745	85.0	1	SNP	p	T316P	0	.	.	946	948	ACC	1413	1415	ACC	114;115;114	A,G;C,T;C,G	98,1;99,1;97,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	782	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2745	85.0	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1914	1916	ACC	127;125;125	A;C;C	115;109;113	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	782	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2745	85.0	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1968	1970	GCG	127;126;124	G;C;G	111;108;107	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	782	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2745	85.0	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1968	1970	GCG	127;126;124	G;C;G	111;108;107	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	782	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2745	85.0	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2091	2093	GGT	114;114;116	G;G;T	107;100;106	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	782	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2745	85.0	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2100	2102	AGC	112;111;111	A;G;C	103;101;102	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	782	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2745	85.0	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2118	2120	CCG	109;108;108	C;C;G	90;93;93	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	938	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3624	77.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1916	1918	CCG	91;92;91	C,A;C;G	82,1;84;84	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	592	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2385	74.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	877	877	C	94	C	84	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	128	porB1a	984	297	91.03	porB1a.l15.c4.ctg.1	1357	27.5	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1085	1087	AAT	20;20;20	A;A;T	16;16;16	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	128	porB1a	984	297	91.03	porB1a.l15.c4.ctg.1	1357	27.5	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1088	1090	AAT	20;20;20	A;A;T	16;16;16	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	128	porB1a	984	297	91.03	porB1a.l15.c4.ctg.1	1357	27.5	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1112	1114	GCA	16;16;16	G;C;A	13;13;13	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	128	porB1a	984	297	91.03	porB1a.l15.c4.ctg.1	1357	27.5	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1135	1137	GTA	11;11;11	G;T;A	10;11;11	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	128	porB1a	984	297	91.03	porB1a.l15.c4.ctg.1	1357	27.5	0	.	p	.	0	N237fs	FSHIFT	709	709	A	1144	1144	A	11	A	11	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	596	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	2385	74.2	0	.	p	.	0	G210R	NONSYN	628	630	GGA	1507	1509	AGA	129;130;132	A;G;A	120;120;120	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	596	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	2385	74.2	0	.	p	.	0	S217G	NONSYN	649	651	AGT	1528	1530	GGT	137;140;138	G,T;G;T	126,2;131;127	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	596	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	2385	74.2	1	SNP	p	G120K	1	.	.	358	360	AAG	1237	1239	AAG	138;139;140	A;A,G;G,T	123;126,1;123,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	596	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	2385	74.2	1	SNP	p	A121N	1	.	.	361	363	AAC	1240	1242	AAC	139;139;140	A,C;A,C,G;C	124,2;123,1,1;126	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	596	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	2385	74.2	1	SNP	p	N121D	0	.	.	361	363	AAC	1240	1242	AAC	139;139;140	A,C;A,C,G;C	124,2;123,1,1;126	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1868	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5520	101.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	296	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1422	62.0	1	SNP	p	V57M	1	.	.	169	171	ATG	793	795	ATG	114;114;114	A;T;G,T	104;101;103,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
